Does discontinuing bleomycin due to toxicity increase the risk of lymphoma progression? Real-life data from a homogeneous population of advanced stage Hodgkin lymphoma.
J Chemother
; : 1-8, 2023 Nov 16.
Article
in En
| MEDLINE
| ID: mdl-37974409
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Chemother
Journal subject:
ANTINEOPLASICOS
/
TERAPIA POR MEDICAMENTOS
Year:
2023
Document type:
Article
Affiliation country:
Turquía
Country of publication:
Reino Unido